TSFG, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 44 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 3.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
TSFG, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$20.0%1600.0%0.00%0.0%
Q2 2023$20.0%1600.0%0.00%0.0%
Q1 2023$20.0%1600.0%0.00%0.0%
Q4 2022$2
-99.8%
1600.0%0.00%
Q3 2022$1,0000.0%1600.0%0.00%
Q2 2022$1,0000.0%1600.0%0.00%
Q1 2022$1,0000.0%1600.0%0.00%
Q4 2021$1,0000.0%1600.0%0.00%
Q3 2021$1,0000.0%1600.0%0.00%
Q2 2021$1,0000.0%1600.0%0.00%
-100.0%
Q1 2021$1,0000.0%1600.0%0.00%0.0%
Q4 2020$1,0000.0%1600.0%0.00%0.0%
Q3 2020$1,0000.0%1600.0%0.00%0.0%
Q2 2020$1,0000.0%1600.0%0.00%0.0%
Q1 2020$1,0000.0%1600.0%0.00%0.0%
Q4 2019$1,0000.0%1600.0%0.00%0.0%
Q3 2019$1,0000.0%1600.0%0.00%0.0%
Q2 2019$1,0000.0%1600.0%0.00%0.0%
Q1 2019$1,0001600.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Newtyn Management, LLC 362,335$3,714,0000.57%
Rubric Capital Management LP 410,244$4,205,0000.52%
WITTENBERG INVESTMENT MANAGEMENT, INC. 83,811$859,0000.37%
Yakira Capital Management, Inc. 83,969$861,0000.28%
KEMPNER CAPITAL MANAGEMENT INC. 14,898$153,0000.10%
STONEBRIDGE CAPITAL MANAGEMENT INC 18,550$200,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 66,498$681,0000.05%
Cannell & Co. 75,467$774,0000.03%
Trexquant Investment LP 21,347$219,0000.02%
PDT Partners, LLC 58,004$595,0000.02%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders